Endocrinology and Metabolism Clinics of North America

Papers
(The TQCC of Endocrinology and Metabolism Clinics of North America is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Dosimetry in Advanced Thyroid Cancer140
Presentation and Care for Children with Peripheral Precocious Puberty118
Precocious and Delayed Puberty Revisited116
Disparities in Thyroid Care85
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes66
Pathobiology of Metabolic-Associated Fatty Liver Disease55
Copyright37
Delayed Puberty Including Constitutional Delay36
Lipid Disorders and Pregnancy31
The Interaction Between Sex and Thyroid Cancer Development and Management30
The Inherited Hypercholesterolemias27
Less-Intensive Management Options for Low-Risk Thyroid Cancer26
Fertility Considerations in Hypogonadal Men26
Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults25
Hereditary Primary Hyperparathyroidism25
Contributors21
The Effects of Testosterone Treatment on Cardiovascular Health21
Subclinical Hypothyroidism and Thyroid Autoimmunity in Pregnancy21
Global Health Disparities in Childhood Rickets19
Nonalcoholic Fatty Liver Disease19
Hypercalcemia of Malignancy18
Bone Metabolism, Bone Mass, and Bone Structure During Pregnancy and Lactation18
Social Determinants of Health Screening in Type 1 Diabetes Management17
Disparities in the Diagnosis and Management of Polycystic Ovarian Syndrome in Adolescents16
Update on Endocrine Disorders During Pregnancy16
Rare Causes of Hypercalcemia15
Update in Papillary Thyroid Cancer15
New and Emerging Therapies for Dyslipidemia15
Copyright15
Intermittent Fasting14
Contents14
Building an Infrastructure to Address Racial Disparities in Treatment and Outcomes in Children with Type 1 Diabetes14
Contributors14
Diagnosis, Treatment, and Outcomes of Males with Central Precocious Puberty14
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence14
Lipid and Lipoprotein Metabolism13
Perspectives on Prediabetes and Aging13
Metabolic-Associated Fatty Liver Disease and Diabetes12
Testosterone, Diabetes Risk, and Diabetes Prevention in Men12
What Is a Honeymoon in Type 1, Can It Go into Remission?12
Forthcoming Issues12
Contents12
Anaplastic Thyroid Cancer11
Contents11
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota11
Contents11
Minimally Invasive Techniques for the Management of Thyroid Nodules11
Contents10
Contributors10
Quality of Life in Patients with Adrenal Insufficiency10
Endocrine Disorders During Pregnancy9
Root Cause for Metabolic Syndrome and Type 2 Diabetes9
Lipid Disorders and Metabolic-Associated Fatty Liver Disease9
The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment9
Age-Associated Abnormalities of Water Homeostasis9
Nutrient-Stimulating Hormone-Based Therapies for Obesity9
Advancing Obesity Medicine9
Treatment of Central Precocious Puberty with a Focus on Girls9
Novel Therapeutics for Advanced Differentiated Thyroid Cancer8
Contents8
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease8
Remission with an Intervention8
Type 1 Diabetes8
The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men8
Metabolic-Associated Fatty Liver Disease8
Isolated Vaginal Bleeding Before the Onset of Puberty7
Dyslipidemia in Diabetes7
Patient-Reported Outcomes in Endocrine Diseases7
Health Disparities and Disrupted Puberty in Males7
Growth Hormone and Aging7
An Update on Redifferentiation Therapy for Radioiodine Refractory Thyroid Cancer7
Type 1 Diabetes and Aging7
Copyright7
Metabolic-Associated Fatty Liver Disease and Sarcopenia7
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period7
Copyright6
Diabetes Remission6
Copyright6
Sociodemographic Factors in Pituitary Adenomas6
Forthcoming Issues6
Sex Hormones and Cardiovascular Disease in Relation to Menopause6
0.054661989212036